Using PK/PD
Goals:
- Identify specific exposure measures (AUC, Cmax, Cmin) that are related to PD endpoints.
- Design exposure-response studies that will allow the assessment of the clinical implications of changing formulations or dosing regimens of antiretroviral drugs.